Bottom line
What is BIVIX's expense ratio?
BIVIX's expense ratio is 3.05%, or about $305 a year on every $10,000 invested. That is more expensive than 99% of large blend funds we track (median 0.83%). It has no front-end sales load.
Updated Mar 2, 2026
BIVIX fee table
| Net expense ratio | 3.05% |
|---|---|
| Gross expense ratio | 3.07% |
| Management fee | 1.74% |
| 12b-1 (distribution) fee | 0% |
| Other expenses | 1.32% |
| Acquired fund fees | 0.01% |
| Fee waiver / reimbursement | -0.02% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
| Redemption fee | -1% |
Source: Fund prospectus fee table, filed Mar 2, 2026
What BIVIX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| BIVIX | $308 | $946 | $1,609 | $3,382 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 3.05% expense ratio costs roughly $141,800 in lost growth, versus about $46,700 for the median large blend fund (0.83%).